WebJan 28, 2024 · CSL. Revenue: $10.49 billion. CSL is a leading Australian biotech company with a portfolio of medicines that treats some immune deficiencies as well as vaccines that help prevent influenza. Unlike ... WebSep 30, 2024 · Csl revenue is $8.5B annually. After extensive research and analysis, Zippia's data science team found the following key financial metrics. Csl has 25,000 employees, and the revenue per employee ratio is $341,560. Csl …
Carlisle Companies Incorporated Common Stock (CSL) Revenue EPS - Nasdaq
WebMar 10, 2024 · In Forbes Magazine’s annual rankings, global biotech leader CSL has landed among America’s Best Large Employers for 2024. With 25,000 employees worldwide – and 16,000 in the United States – CSL ranked among the top 500. Across 25 industry sectors, the Forbes rankings measure how well a company is meeting the needs and … WebApr 12, 2024 · CSL’s price/sales is 8.66. Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues. small autism clip art
Credit Suisse Maintains Carlisle Companies (CSL) Outperform ...
WebJul 18, 2024 · View CSL (www.csl.com) location in Victoria, Australia , revenue, industry and description. Find related and similar companies as well as employees by title and … WebJan 28, 2024 · Revenue: $10.49 billion. CSL is a leading Australian biotech company with a portfolio of medicines that treats some immune deficiencies as well as vaccines that help prevent influenza. Unlike some other leading Australian companies, CSL gets a substantial part of its sales internationally. In terms of its biggest division, CSL Behring, whose ... WebPioneering the development of iron-based products and establishment as a leader in the treatment of iron deficiency. Highlights 2024: Ferinject® granted new recommendations … solidworks pagina oficial